Copyright
©The Author(s) 2025.
World J Hepatol. Sep 27, 2025; 17(9): 110049
Published online Sep 27, 2025. doi: 10.4254/wjh.v17.i9.110049
Published online Sep 27, 2025. doi: 10.4254/wjh.v17.i9.110049
Figure 1 Albumin-bilirubin score/grade distribution in relation to the degree of baseline liver fibrosis.
aP < 0.001. ALBI: Albumin-bilirubin.
Figure 2 Receiver operating characteristic curves for prediction of liver fibrosis.
A: Albumin-bilirubin score; B: Aspartate aminotransferase/alanine aminotransferase ratio; C: Aspartate aminotransferase to platelet ratio index; D: Fibrosis-4 index. ALBI: Albumin-bilirubin; ROC: Receiver operating characteristic; AST/ALT: Aspartate aminotransferase/alanine aminotransferase ratio; APRI: Aspartate aminotransferase to platelet ratio index; FIB-4: Fibrosis-4 index.
- Citation: Ewid M, Sherif H, Saquib N, Alammari AM, Ismail AAM, Alkahlot MH, Ahmed ZT, Al-Zabidi FZM, Al Mutiri N. Albumin-bilirubin score reflects the extent of liver fibrosis in chronic hepatitis C patients treated with direct-acting antivirals. World J Hepatol 2025; 17(9): 110049
- URL: https://www.wjgnet.com/1948-5182/full/v17/i9/110049.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i9.110049